But now the shortage that enables much of this business appears to be on the verge of ending potentially before that FDA commissioner takes office which would force Hims to pursue more creative options
doi: 10.1002/14651858.cd010567.pub2
In older adults, oxybutynin is associated with increased risk of central nervous system adverse effects, including confusion and cognitive impairment, warranting caution in patients with dementia or other geriatric vulnerabilities
Abstract The global incidence of steatotic liver disease (SLD), driven by metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-associated liver disease (ALD), and the synergistic metabolic dysfunction and alcohol-associated liver disease (MetALD), is fueling a rapid rise in hepatocellular carcinoma (HCC)
While 8% of adults ages 65 and older say they have taken a GLP-1 medication for a chronic condition, just 1% say they have ever taken a GLP-1 drug to lose weight, which may reflect Medicares lack of coverage for prescription drugs used for weight loss
10.2337/db09-0063 99
